Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)

计划入组 2 人 · 首次发布于 2021 年 12 月 3 日

Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers

计划入组 24 人 · 首次发布于 2012 年 11 月 8 日

TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis

计划入组 80 人 · 首次发布于 2005 年 9 月 28 日

TRXE-009

TRX-E-002-1

C₂₄H₂₄O₆

HT-002-01

01 Communique Laboratory Inc

Canada

Miragen Therapeutics, Inc.

Renovaro

United States

Kazia Therapeutics Sells Cantrixil Intellectual Property Rights to Vivesto for $1 Million

PleoPharma Doses First Patient in Pivotal Phase 3 Trial of PP-01 for Cannabis Withdrawal, Presents Phase 2 Data Showing 43% Reduction in Irritability

Cothera Bioscience's PC-002 Receives FDA Fast Track for Burkitt Lymphoma